PNTG
Pennant Group Inc
NASDAQ: PNTG · HEALTHCARE · MEDICAL CARE FACILITIES
$41.08
-2.24% today
Updated 2026-07-29
Market cap
$1.46B
P/E ratio
48.30
P/S ratio
1.43x
EPS (TTM)
$0.87
Dividend yield
—
52W range
$22 – $43
Volume
0.3M
WallStSmart proprietary scores
51
out of 100
Grade: C
Hold
Investment rating
8.7
Growth
A4.0
Quality
C5.5
Profitability
C+4.3
Valuation
C1/9
Piotroski F-Score
Weak
1.7
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$45.00
+9.54%
12-Month target
$31.50
-23.32%
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Revenue growth 36.00% QoQ
Risks
- Piotroski 1/9 — weak financial health
- Altman Z 1.69 — distress zone
- Thin margins at 2.96%
- Negative free cash flow $-8.68M
- P/E 48.30x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $473.24M | $544.89M | $695.24M | $947.71M | $1.02B |
| Net income | $6.64M | $13.38M | $22.56M | $29.58M | $8.52M |
| EPS | — | — | — | — | $0.87 |
| Free cash flow | $-5.13M | $24.98M | $30.31M | $26.30M | $-8.68M |
| Profit margin | 1.40% | 2.46% | 3.24% | 3.12% | 2.96% |
Peer comparison
Smart narrative
Pennant Group Inc trades at $41.08. representing a P/E of 48.30x trailing earnings. Our Smart Value Score of 51/100 indicates the stock is fair. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of 1.69, it sits in the distress. TTM revenue stands at $1.02B. with profit margins at 2.96%.
Frequently asked questions
What is Pennant Group Inc's stock price?
Pennant Group Inc (PNTG) trades at $41.08, on a P/E of 48.3x and a P/S of 1.4x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Pennant Group Inc overvalued?
Pennant Group Inc carries a Smart Value Score of 51/100 (Grade C), which we rate Hold. That score blends growth, quality, and valuation into one read.
What is the price target of Pennant Group Inc (PNTG)?
The 12-month analyst consensus target is $45.00, about 9.5% above the current $41.08. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Pennant Group Inc's revenue?
Pennant Group Inc's trailing twelve-month revenue is $1.02B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Pennant Group Inc's Altman Z-Score is 1.69, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.43x
ROE9.98%
Beta1.25
50D MA$36.24
200D MA$31.14
Shares out0.03B
Float0.03B
Short ratio—
Avg volume0.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—